Mosaic Therapeutics welcomes new CEO. Former Cimeio Therapeutics CEO Thomas Fuchs has taken the helm at Mosaic Therapeutics, ...

Whilst there, pharmaphorum editor-in-chief Jonah Comstock and web editor Nicole Raleigh, together with Frontiers Health ...

Bayer has billed Lynkuet as its next major pharma launch, saying it is due to start rolling out in the US later this month, ...

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could ...

The approval puts Lunsumio on the same footing as Epkinly (epcoritamab) in FL – a form of non-Hodgkin lymphoma (NHL) – as ...

Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a ...

Shortly after Alkermes and Avadel announced their deal, Lundbeck made an unsolicited offer of $23 per share, including $21 ...

At Frontiers Health 2025, we capturedoff-stage conversations with Renzo DiCarlo (AstraZeneca) and James Kugler (EMD Digital), ...

The commercialisation landscape in pharma is undergoing rapid transformation. At Frontiers Health 2025, we took the ...

At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial ...

The role of Medical Affairs within the pharmaceutical industry is to generate and disseminate evidence to healthcare ...

Moderated by pharmaphorum’s web editor Nicole Raleigh, the session featured three expert panellists: Mo Rice, Vice President ...